We are live on ! Find out more
PAG

Private Advisor Group Portfolio holdings

AUM $21.8B
1-Year Est. Return 28.57%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+28.57%
3 Year Est. Return
+77.38%
5 Year Est. Return
+84.64%
10 Year Est. Return
+284.62%
AUM
$14.9B
AUM Growth
+$991M
Cap. Flow
+$848M
Cap. Flow %
5.69%
Top 10 Hldgs %
18.54%
Holding
2,500
New
179
Increased
1,234
Reduced
875
Closed
147

Sector Composition

Rank Sector Weight
1 Technology 10.35%
2 Financials 4.27%
3 Healthcare 3.31%
4 Consumer Discretionary 3.14%
5 Industrials 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BB icon
2251
BlackBerry
BB
$4.95B
$78.3K ﹤0.01%
31,558
+70
+0.2% +$195
PMM
2252
Franklin Managed Municipal Income Trust
PMM
$269M
$77.9K ﹤0.01%
12,561
+91
+0.7% +$546
ARIS
2253
Aris Mining
ARIS
$2.81B
$75.2K ﹤0.01%
20,000
CGC
2254
Canopy Growth
CGC
$380M
$70.3K ﹤0.01%
+10,893
New +$93.7K
LUMO
2255
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$69.6K ﹤0.01%
30,013
+14,000
+87% +$36.2K
KEEL
2256
Keel Infrastructure Corp
KEEL
$2.42B
$69.2K ﹤0.01%
26,926
+1,000
+4% +$2.15K
BNO icon
2257
United States Brent Oil Fund
BNO
$783M
$69.1K ﹤0.01%
2,150
-2,597
-55% -$82K
ESPR
2258
DELISTED
Esperion Therapeutics
ESPR
$67K ﹤0.01%
30,170
+1,342
+5% +$3.16K
CMU
2259
DELISTED
MFS High Yield Municipal Trust
CMU
$65.5K ﹤0.01%
19,093
CTMX icon
2260
CytomX Therapeutics
CTMX
$686M
$63.7K ﹤0.01%
52,179
-17,000
-25% -$33.8K
DH icon
2261
Definitive Healthcare
DH
$72.8M
$60.9K ﹤0.01%
+11,147
New +$70.2K
AKBA icon
2262
Akebia Therapeutics
AKBA
$351M
$60.8K ﹤0.01%
+59,626
New +$73.7K
AMC icon
2263
AMC Entertainment Holdings
AMC
$2.44B
$58.6K ﹤0.01%
+11,774
New +$47.3K
UNIT
2264
Uniti Group
UNIT
$2.28B
$57.6K ﹤0.01%
19,729
-5,261
-21% -$22K
OPEN icon
2265
Opendoor
OPEN
$3.6B
$57.2K ﹤0.01%
32,106
+1,273
+4% +$2.75K
ACHR icon
2266
Archer Aviation
ACHR
$3.53B
$55.2K ﹤0.01%
15,675
-165
-1% -$612
MTNB icon
2267
Matinas BioPharma
MTNB
$1.92M
$54.9K ﹤0.01%
6,941
PHK
2268
PIMCO High Income Fund
PHK
$871M
$54K ﹤0.01%
11,210
-2,465
-18% -$11.9K
XTNT icon
2269
Xtant Medical Holdings
XTNT
$58.9M
$53.5K ﹤0.01%
85,000
+47,500
+127% +$37.9K
LUMN icon
2270
Lumen
LUMN
$6.69B
$53.4K ﹤0.01%
48,025
-35,951
-43% -$45.6K
BDN
2271
Brandywine Realty Trust
BDN
$520M
$50.9K ﹤0.01%
+11,355
New +$51.7K
SACH
2272
Sachem Capital Corp
SACH
$39.3M
$50.7K ﹤0.01%
19,568
-5,177
-21% -$16K
DUOT icon
2273
Duos Technologies
DUOT
$271M
$50.2K ﹤0.01%
17,556
-26,000
-60% -$74.1K
CHPT icon
2274
ChargePoint
CHPT
$139M
$49.1K ﹤0.01%
1,624
-630
-28% -$20.5K
ONL
2275
Orion Office REIT
ONL
$149M
$48.8K ﹤0.01%
13,598
+564
+4% +$1.93K

Similar funds

Private Advisor Group's Q2 2024 Portfolio in Review

As of Q2 2024, Private Advisor Group held 2,500 positions worth $14.9B, up 7.1% from $13.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Private Advisor Group deployed $848M of net new capital in Q2 2024, opening 179 new positions and adding to 1,234 existing holdings. Its largest new stake was T. Rowe Price Growth ETF: 348,004 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $28.3M trimmed.

  • Private Advisor Group's largest Q2 2024 buy was T. Rowe Price Growth ETF: 348,004 shares worth $12.1M.
  • Private Advisor Group added most to Apple in Q2 2024, an estimated $37.7M increase.
  • Private Advisor Group's biggest Q2 2024 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $28.3M.
  • Private Advisor Group fully exited First Trust Equity Market Neutral ETF in Q2 2024, selling an estimated $4.46M.
  • Private Advisor Group's ten largest holdings make up 19% of its $14.9B portfolio in Q2 2024.
  • Private Advisor Group opened 179 new positions and closed 147 in Q2 2024.
  • Private Advisor Group's portfolio value rose 7.1% quarter-over-quarter to $14.9B.

Based on Private Advisor Group's 13F filing for Q2 2024, filed 5 Aug 2024.